Adriano Lazzarin
Ospedale San Raffaele · San Raffaele Hospital - Milan · San Raffaele Hospital - Milan, Italy
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adriano Lazzarin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:36 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03493568 · Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)IRCCS San Raffaele · terminated · HIV-1-infection · principal investigator
- Ph2NCT02542852 · A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable ViremiaCastagna Antonella · completed · HIV-1 Infection · principal investigator
- Ph3NCT01511809 · Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral SuppressionIRCCS San Raffaele · completed · HIV-1 Infection · principal investigator
- N/ANCT01029548 · Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult SubjectsBarbara Ensoli, MD · completed · HIV Infections · principal investigator
- N/ANCT01024595 · Observational Study of the Therapeutic Study of Recombinant HIV-1 TATIstituto Superiore di Sanità · completed · HIV Infection · principal investigator
- N/ANCT01024764 · Observational Study of the Preventive Trial With HIV-1 Tat ProteinIstituto Superiore di Sanità · completed · Healthy Subjects · principal investigator
- N/ANCT01024556 · Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult SubjectsBarbara Ensoli, MD · completed · HIV Infection · principal investigator
- Ph3NCT00437684 · Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) TherapyIRCCS San Raffaele · unknown · HIV Infections, Hepatitis C · principal investigator
- Ph3NCT00437476 · Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV TherapyIRCCS San Raffaele · unknown · HIV Infections, Hepatitis C · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:36 UTC. The ranking covers the 200 most relevant of 145 PubMed records, and a shared surname and initials can bring in a namesake. All 145 on PubMed
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.N Engl J Med · 20041,033 citationsRCR 26.4
- Raltegravir with optimized background therapy for resistant HIV-1 infection.N Engl J Med · 2008567 citationsRCR 15.3
- Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.N Engl J Med · 2003546 citationsRCR 12.5
- 519 citationsRCR 15.0
- 458 citationsRCR 11.8
- 431 citationsRCR 11.2
- 405 citationsRCR 10.7
- 361 citationsRCR 10.1
- 351 citationsRCR 11.2
- 342 citationsRCR 15.3